United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 150 mg - bupropion hydrochloride extended-release tablets (sr) are indicated for the treatment of major depressive disorder. the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled trials of depressed inpatients and in one 6-week controlled trial of depressed outpatients whose diagnoses corresponded most closely to the major depression category of the apa diagnostic and statistical manual (dsm) (see clinical pharmacology). a major depressive episode (dsm-iv) implies the presence of 1) depressed mood or 2) loss of interest or pleasure; in addition, at least 5 of the following symptoms have been present during the same 2-week period and represent a change from previous functioning: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a

United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. - ammonium chloride (unii: 01q9pc255d) (ammonium cation - unii:54s68520i4) -

United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. - ammonium chloride (unii: 01q9pc255d) (ammonium cation - unii:54s68520i4) -

United States - English - NLM (National Library of Medicine)

wockhardt limited - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 150 mg - bupropion hydrochloride extended-release tablets (xl) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with mdd. the efficacy of the sustained-release formulation of bupropion in the maintenance treatment of mdd was established in a long-term (up to 44 weeks), placebo-controlled trial in patients who had responded to bupropion in an 8-week study of acute treatment [see clinical studies (14.1)] . bupropion hydrochloride extended-release tablets (xl) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (sad). the efficacy of bupropion hydrochloride extended-release tablets in the prevention of seasonal major depressive episodes was established in 3 placebo-controlled trials in ad

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

e.e. muir & sons pty limited - ammonium sulphate; ammonium sulphate - granular formulation - ammonium sulphate ammonium active 990.0 g /kg; ammonium sulphate ammonium active 980.0 g/kg - adjuvant - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - improve performance | tank mixing | additive | agricultural chemical | herbicide | minimise antagonism | spray tank | under adverse environmental co

United States - English - NLM (National Library of Medicine)

unit dose services - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 300 mg - tramadol hydrochloride extended-release tablets is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. limitations of use - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see warnings and precautions (5.1)], reserve tramadol hydrochloride extended-release tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. - tramadol hydrochloride extended-release tablets is not indicated as an as-needed (prn) analgesic. tramadol hydrochloride extended-release tablets are contraindicated for: - all children younger than 12 years of age [see warnings and precautions (5.3)] - post-operat

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga manufacturing berhad - ammonium chloride; diphenhydramine hydrochloride -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

swancorp group pty ltd - ammonium sulphate - granular formulation - ammonium sulphate ammonium active 980.0 g/kg - adjuvant - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - improve performance | tank mixing | additive | agricultural chemical | herbicide | minimise antagonism | spray tank | under adverse environmental co

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sykes vet (international) pty. ltd. - citric acid; sodium citrate; ammonium chloride; squill oxymel; tolu syrup; menthol crystals - oral solution/suspension - citric acid acid-general active 45.0 g/l; sodium citrate mineral-sodium-salt active 12.0 g/l; ammonium chloride ammonium active 186.0 g/l; squill oxymel plant active 92.0 ml/l; tolu syrup ungrouped active 120.0 ml/l; menthol crystals terpene active 2.0 g/l - respiratory system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - cough suppression | bronchitis | bronchodilation | cough suppressants | decongestants | expectorants | mucoid secretions | mucolytics | respiratory conditions | sinusitis

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m loveridge ltd - ammonia solution strong; ethanol 90%; lemon oil; nutmeg oil; ammonium chloride; liquorice liquid extract; ammonium bicarbonate - oral solution - 3.375microlitre/1ml ; 1.875microlitre/1ml ; 25nanolitre/1ml ; 15nanolitre/1ml ; 100mg/1ml ; 100microlitre/1ml ; 1.25mg/1ml